Your Position:Products>Antigen/Recombinant Protein

Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5)

货号:EPT085
  • Price:Negotiable
  • Click:1684

Product Detail

基本信息

Size50ug
Expression HostHuman Cells
Tag8A5

物理性质

FormSupplied as a 0.2 μm filtered solution of PBS, pH 7.4

活性与内毒素

ActivityImmobilized 2019-nCoV S Protein RBD-SD1-His(Cat#DRA42)at 2μg/ml (100μl/well) can bind Anti-2019-nCoV S-cIgG1 Antibody (8A5)(Cat#DA036). The ED50 of Anti-2019-nCoV S-cIgG1 Antibody (8A5)(Cat#DA036)is 19.74 ng/ml.

储存与运输

Storage24 months from manufacturing at <-20 °C; 1 month, 2 to 8 °C under sterile conditions.
Shipping ConditionThe product is shipped on dry ice pack.Upon receipt, store it immediately at the temperature listed below.

详细说明

BackgroundThe spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.